chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Expired HPV9 vaccine given to client. Expired 6-15-19 & given 7/10/19. No adverse event expected Mom stated client c/o sore arm. No redness, swelling on 7/11/19 when discussed. Orig notification call 7/10/19 & VM left. Mom returned call 7/11/19. Scheduled client for revaccination 8/7/19
Warmth and swelling to right leg, from mid-thigh to knee - measuring at 29 cm.
Patient felt fine during observation period after receiving Janssen. On his drive home he experienced blurred vision in his right eye that lasted for about 3 minutes. He returned to vaccine site. Doctor on site was called and patient was transferred to the doctor's office for further evaluation. No symptoms of anaphylaxis.  Neurological exam normal. No other symptoms of stroke. Vital signs stable. Patient feels fine. Due to patient's cardiac history, doctor was concerned about a possible  transient ischemic attack. Therefore, he was transferred to the emergency department for further evaluation. Patient declined additional tests in the ED. Patient admitted to the ED, pt with normal exam.  Sx only lasted 2-3 minutes.  Consulted with neurologist.  Does not sound like stroke. Also not suggestive of known J & J vaccine reaction.  Suggest ophth eval.
Patient received 2nd Pfizer COVID Vaccine on 05/07/2021 and patient reports two days later she began to feel increasingly short of breath and was found to be hypoxic at 66% requiring increased supplemental oxygen, thought to be due to sudden COPD exacerbation, requiring IV Solu-medrol, Duo-nebs and Albuterol. Required hospitalization for 2 days and discharged on antibiotics and prednisone.
Patient recieved two vaccines (MCV4-IM and VZV-SubQ) within seconds of recieving VZV patient fell in my arms and began to jerk for 5 seconds, came to unaware of what had happen. Vitals: BP: 88/43, P: 73 Reps: 18. Called 911 transported to Hospital with Fathers consent.
Suspected vaccination failure; Got a really bad case of shingles; Residual nerve damage; Painful symptoms; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Got a really bad case of shingles), nerve damage (Verbatim: Residual nerve damage) and pain (Verbatim: Painful symptoms). The patient was treated with medication unknown (Pill (Medication Unknown)). The outcome of the vaccination failure was unknown and the outcome of the shingles, nerve damage and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, nerve damage and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, nerve damage and pain to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-March-2023 This case was reported by a patient via interactive digital media. The reporter's one of closest friends received the shingles vaccine. The patient got a really bad case of shingles regardless.  The patient really think that the physician killed with all the other pills and medications they gave him to treat all the residual nerve damage and painful symptoms. The follow up would not possible, as no contact, details were available. This case was considered as suspected vaccination failure since the details regarding completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Redness severe, joint pain, fever, shortness of breath, felt really bad. Dr. administered Kenalog, sleep and told me to continue Zyrtec 3x daily.
Approximately 9 hours after vaccination, pain in injection arm became much worse, a pain rating of 6 to touch and on abduction.  About 11 hours after vaccination, I became increasingly uncomfortable, feeling warm, chills, muscle aches.  I could not sleep.  22 hours after vaccination, my temperature was 101 F (did not take it before this time).  Temperature waxed on waned from that point (day #2).  About 36 hours after the vaccine, my temperature stabilized to normal.  48 hours after the vaccine, I felt better and better with each hour.
On day 7, broke out in welts. Entire body covered above hips, including groin, breast, scalp, ears, face, back. Accompanied by intense burning and itch, Treated with CLARITAN am; ZYRTEC pm; TAGAMET 400mg bid; chlorpheniramine 4mg tid; oatmeal baths tid.
Vaccinated with 2 doses of 2 month immunizations < 28 days no adverse reaction reported @ 5 days.
dizziness, bradycardia, sweating, fainted & fell. VS taken, observed, juice offered, symptoms resolved, pt transfer to ED for abrasion on  right side of his forehead
patient got a hard painful lump the size of a small marble about an inch or 2 below the injection site that lasted a couple weeks then slowly went away. no fever. no warmth. not spreading after it appeared.
Fever, throat swelling, red and raised injection site, swollen arm, arm painful to move around/lay on.
injection site raised, red, irritated, warm to touch. LT Thigh: 11/2cm x 1cm Rt thigh: 2cm x 2cm
tenderness; redness; Grew a hive in the point on her shoulder where she received the vaccine that continued to spread; injection site rash which continued to spread; Rash and hives covering the majority of her left arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (tenderness), INJECTION SITE ERYTHEMA (redness), INJECTION SITE URTICARIA (Grew a hive in the point on her shoulder where she received the vaccine that continued to spread), INJECTION SITE RASH (injection site rash which continued to spread) and RASH (Rash and hives covering the majority of her left arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced TENDERNESS (tenderness), INJECTION SITE ERYTHEMA (redness), INJECTION SITE URTICARIA (Grew a hive in the point on her shoulder where she received the vaccine that continued to spread), INJECTION SITE RASH (injection site rash which continued to spread) and RASH (Rash and hives covering the majority of her left arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, TENDERNESS (tenderness), INJECTION SITE ERYTHEMA (redness), INJECTION SITE URTICARIA (Grew a hive in the point on her shoulder where she received the vaccine that continued to spread), INJECTION SITE RASH (injection site rash which continued to spread) and RASH (Rash and hives covering the majority of her left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
This spontaneous report as received from a pharmacy technician refers to a 36 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 12-MAR-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1802USA001558.
day after the  administration patient presents very high fever with severe pain in the injection site., received  attention in emergency room abd was diagnosed with cellulitis in the arm. Was in hospital until 04/02/2021.  Now in her home.
This spontaneous report as received from a pharmacist via a company representative refers to a patient of unknown age. On an unknown date the patient was vaccinated with the second dose of PNEUMOVAX23 and had an adverse reaction. It was unknown if the patient sought medical attention. The outcome of adverse reaction and relationship was unknown. Additional information is not expected.
white flashes, stringing black things in visual field, rt eye; intermittently:  arthralgias, nausea, vomiting, weight loss, fever, fatigue & muscle weakness; rt eye deteriorated; dx rt retinal necrosis & 1999 dx w/Raynaud's disease
UNSPECIFIED ADVERSE EVENT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included omalizumab. On an unspecified date, the subject experienced unspecified adverse event. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse event was not reported. This report was non-serious.
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Hyperventilation-Mild, Systemic: Seizure-Mild, Systemic: Tachycardia-Mild
Pt. had 2 febrile seizures on 12/10/08, 1 day after receiving vaccines.
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of NO ADVERSE EVENT (No adverse event) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, NO ADVERSE EVENT (No adverse event) and EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used).    No concomitant medication information was provided. The vial was initially stored in refrigerator on 7-Jun-2022. The vial did not undergo any temperature excursions. The dates of administration of the vaccines was reported as 1Apr2022, 5Apr2022, 6Apr2022, 8Apr2022, 11Apr2022, 12Apr2022, 13Apr2022, 14Apr2022, 22Apr2022, 9Jun2022, 10Jun2022, 13Jun2022, 18Jun2022 and 22Jun2022.  The dates of vaccine administration were not reported and it was unknown whether patient took first, second or first and or second booster doses. No treatment medication information was provided.   This case was linked to MOD-2022-589423 (E2B Linked Report).; Sender's Comments:  MOD-2022-589423:Master case
Feeling almost immediate tiredness within 10 mins of injection. Fatigue set in around 3-4 hrs later with mild fever around 10PM same night. Mild fever (under 100 F) all day the next day with bedridden fatigue
Low grade fever; Fever started at 100.4 and ever since it has been bouncing back and forth to below 98.6 and also above it like 99; Fatigue; Sleeping a lot; Nausea; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection; Lot number: unknown; Expiration date: unknown), via unspecified route of administration on 23Feb2021 as 1st dose, single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On 04Mar2021, 9 days after the vaccination, the patient experienced low grade fever; fever started at 100.4 and ever since it has been bouncing back and forth to below 98.6 and also above it like 99, fatigue, sleeping a lot and nausea. The patient did not know whether that was normal because on the day of reporting, the patient came up with temperature 99 that morning and now it was normal. The patient had a little bit of nausea which went away after couple of hours. It was very mild symptoms and the patient wanted to know if it was due to the shot. The outcome of the nausea was resolved on unknown date, and was unknown for all other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
After the first injection I had a quite of significant response in left arm and also in the right arm; something was happening to my body; After the first injection I had a quite of significant response in left arm and also in the right arm; something was happening to my body; This is a spontaneous report received from contactable reporter(s) (Physician and Consumer or other non-HCP). The reporter is the patient.  A 94-year-old male patient received bnt162b2 (BNT162B2), administration date 01Mar2021 17:00 (Lot number: EN6205) at the age of 94 years as dose 1, single for covid-19 immunisation. Relevant medical history included: don't see well (unspecified if ongoing); don't hear well (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), DISCOMFORT (non-serious), outcome unknown and all described as After the first injection I had a quiet of significant response in left arm and also in the right arm; something was happening to my body.  Additional information: Consumer (Doctor) stated, I have my injection on Monday at 05:00 pm and I have had no reaction to it at all. I had my first injection in past. This is my second injection. After the first injection I had a quiet of significant response in left arm and also in the right arm for more than 2 days. I knew that something was happening to my body. I was responding to the injection but for this one like my second injection I had zero response anyway. Until what I am quite sure of is this the batch which I got was inactivated. So, I am quite sure I didn't get the second injection. I got the injection, but I am sure, I believe that product was inactivated for my second shot. What do you think There is two things first of all I wanted to give you the batch number because I believe I got the batch was inactive. So, I want to give you the batch number.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Shoulder became sore (too sore to raise arm), small lump formed size about 1/2 cm. No redness, warmth or fever.
Generalized pain that started on the extremities and has moved to the spineal column. Symptoms were present prior to vaccine but have worsened. Started roughly 3 days post vaccination. OTC pain medication lessens symptoms. Pain is constant and randomly spikes.
Pt. was given PROQUAD SQ in the right arm and KINRIX and Hep A IM in the left arm on 4-16-17 pm. On 4-17-18 Pt. dad noticed swelling on the right arm about the size of a 50 cent piece. On 4-18-18 dad bought the pt in to be seen for a knot, warmth and redness at the injection site.and the pt. was seen by the provider DNP, CNM, FNP-C at Health Department. Employee prescribed the pt. Cetrizine HCL 5 ml daily and Prednisolone 10 ml daily and to come back on 4-20-18 to be rechecked by the nurse. Employee dx. the pt. with Adverse Effects of Other Viral Vaccines Initial Encounter.
Loss of taste that comes and goes.  It almost feels like my tongue is numb.  It's been 15 days and I still experience partial loss of taste in waves.
Patient initially presented to Urgent Care after falling at home. He was found to be febrile temperature 102 and had a cough symptoms.  The patient was diagnosed COVID infection and pneumonia  his O2 saturations dropped, was found initially hypoxic. He required high-flow oxygen . He was started on decadron, remesdevir and later on baricitinib as well. Pt required HFNC oxygen for while and was subsquently weaned down and discharged.
Took two weeks to go away/arthritis went away/ I've not had a pain since; Gouty arthritis; This spontaneous case was reported by a consumer and describes the occurrence of GOUTY ARTHRITIS (Gouty arthritis) and THERAPEUTIC RESPONSE UNEXPECTED (Took two weeks to go away/arthritis went away/ I've not had a pain since) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.   On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced GOUTY ARTHRITIS (Gouty arthritis). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Took two weeks to go away/arthritis went away/ I've not had a pain since). At the time of the report, GOUTY ARTHRITIS (Gouty arthritis) and THERAPEUTIC RESPONSE UNEXPECTED (Took two weeks to go away/arthritis went away/ I've not had a pain since) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  The patient went on a common medicine that treats gouty arthritis. He does not know the name of it.
to be hospitalized with shingles, suspected vaccination failure; shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: to be hospitalized with shingles, suspected vaccination failure) (serious criteria hospitalization and GSK medically significant) and shingles (Verbatim: shingles) (serious criteria hospitalization). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 02-MAR-2023 This case was reported by a consumer via interactive digital media. The reporter reported that got chicken pox as a full grown adult even after he or she had childhood shots doctor said to get the shingles shot because of this.  The reporter had really bad side effects and his or her coworker had to be hospitalized with shingles. The reporter said great that he or she did not get shingles chicken pox was the worst. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming Shingles were unknown at the time of reporting. Follow-up would not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR038391:Same reporter
Rash at injection site, Body aches, chills, dizzy, nausea & low grade fever.  These symptoms started at 2am on 12/29/2021 and ended at 4:40 am then reoccurred on 12/30/2021 in evening for a couple hours and then disappeared.
Left eye being swollen almost shut with some clear discharge; Left eye being swollen almost shut with some clear discharge; Half of the right side of her face was swelling and being numb; Half of the right side of her face was swelling and being numb; On and off chills; Sweating; Headache; Fever; This is a spontaneous report from a contactable healthcare professional (patient). A non-pregnant 27-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EJ1685), via an unspecified route of administration in left arm, on 31Dec2020 at 09:30, at a single dose, for COVID-19 immunization. The patient's medical history included enlarged thyroid (normal for her), painful menstruations, allergies to cats, dogs, and dust, seasonal allergies, and birth control. The patient's concomitant medication included ethinylestradiol/ norethisterone acetate (JUNEL) as birth control. The patient was not diagnosed with COVID-19 prior vaccination. No other vaccine was administered in four weeks. The vaccine was administered in a hospital facility. On 12Jan2021 at 06:15 AM, the patient woke up from sleep with her left eye being swollen almost shut with some clear discharge and half of the right side of her face was swelling and being numb. This persisted for about 3 days with on and off chills, sweating, headache, and a fever on 12Jan2021 (06:15). The symptoms completely dissipated on 22Jan2021. The adverse events resulted in doctor or other healthcare professional office or clinic visit. No treatment was received for the events. The patient got a COVID-19 test on 13Jan2021 just to be safe which came back as negative. The patient recovered from the events on 22Jan2021.
A 6 month old patient was given HIBERIX as part of their primary HIB series. The vaccine was given. Dose will count & not need to be repeated per CDC guidelines. Private office. Medications involved were HIB vaccine and HIBERIX. Injectable; 0.5mL of HIBERIX. No adverse reaction noted. Error was discovered after injection given during documentation.
administered the liquid conjugate only (without the lyophilized portion); administered the liquid conjugate only (without the lyophilized portion); This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA391A, expiry date 20th July 2022) for prophylaxis.   On 13th May 2021, the patient received Menveo. On 13th May 2021, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.  Additional details were provided as follows: The nurse practitioner administered only liquid conjugate of Menveo (without lyophilized portion) to the patient, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reported batch number AMXA391A was not found in sales data sheet, hence was updated to AMVA391A. No symptoms were reported. The reporter consented to follow up.
Non pitting edema with small rash <1 cm.  Area warm to touch - c/o muscle & joint discomfort afebrile at 96.0 - ibuprofen or TYLENOL for discomfort.  RTC PRN f/u PCI of s/s change.  C/O reaction to Td vaccine.